Expert & Member Meeting 2023

In December, Budapest gave place to C-EHRN’s Expert & Member Meeting, with more than 130 professionals gathering to discuss the key activities of the network!

To find out more about the event and C-EHRN’s key activities, watch the inspiring video by the Rights Reporter Foundation, and look at the summary of the event below.

On Monday the 4th, our focal points discussed the civil society monitoring of harm reduction in Europe process, ways to use the C-EHRN Monitoring data for advocacy purposes and getting familiar with a new data collection and visualisation tool for the C-EHRN monitoring activities. In the meantime, the partners of the Drug-Prep Project had insightful discussions on foresight research and other project activities.

 

A press conference also took place, introducing drug consumption rooms, drug checking in Europe and the example of Portugal’s health-based drug policy approach, sharing the message that “not only the richest countries in the world can implement efficient drug policies based on decriminalisation” (Marta Pinto, University of Porto). As a result, the conference gained coverage in RTL, one of Hungary’s most popular commercial TVs.

At the end of the day, some meeting participants visited Válaszút Misszió Drogkonzultációs Iroda, learning about their services and the Hungarian context.

Tuesday began with C-EHRN’s director, Katrin Schiffer, opening the official programme for all participants of the event, also introducing C-EHRN’s new visual identity which we launched with the event! During the plenary sessions, we discussed various topics including drug policy and harm reduction in Hungary, civil society monitoring and data collection, and some of the network’s main activities, including research on harm reduction in prison and harm reduction and gender.

Throughout the afternoon’s parallel sessions, we also talked about infectious diseases in community-based settings in the context of the BOOST project, while a migration workshop took place through the SEMID-EU project, and those interested could find out about the application of foresight research in the context of the drugs field (Drug-Prep project). In the following sessions, the civil society involvement case studies conducted in 4 European countries were discussed, while we also spoke about drug consumption rooms and mental health.

Wednesday’s parallel sessions gave space for an engaging conversation about C-EHRN’s strategy for 2024-2028, while drug checking and the state of harm reduction in five European cities (Amsterdam, Bălţi, London, Esch-sur-Alzette and Warsaw) were also discussed.

The Semid-EU plenary delved into the needs and (harm reduction) service access of marginalised migrants who use drugs in the EU, after which we reflected on the outcomes of the time spent together at the member & expert meeting.

To capture the event, we bring you a collection of images below.

Follow some of the sessions of our 2023 Expert & Member Meeting online!

We are happy to announce that during our 2023 Expert & Member Meeting, some of the sessions on Tuesday the 5th and Wednesday the 6th of December will be streamed online!

 
 

The plenary sessions on Tuesday the 5th of December can be followed via this link. The streamed plenary sessions are the following:

  • 9.30-9.50 Welcome & Opening
    Moderator: Tony Duffin (Ana Liffey Drug Project)
    Speakers: Gabor Kerpel-Fronius; Deputy Mayor of Budapest & Katrin Schiffer, C-EHRN Director
    This session will include welcome words and an introduction to C-EHRN activities and results.
  • 9.50-10.10 Keynote Speech – Drug Policy and HR in Hungary
    Moderator: Tony Duffin (Ana Liffey Drug Project)
    Speaker: Péter Sárosi (Rights Reporter Foundation)
    Harm reductionists face different political and cultural realities in different geographical regions of Europe. In some countries in the West the question today is mainstreaming and innovation. But in other countries, mostly in the East, even basic harm reduction programs are confronted with a more existential question: that of mere survival. There is a growing populism and shrinking space for civil society. On top of this, the drug scene is changing and constantly challenges us to find new methods, to reach out to new groups and to redefine what harm reduction means. The keynote speech will address the challenges and highlight some opportunities ahead of the harm reduction movement in Europe.
  • 10.10-11.00 Policy Dialogue
    Moderator: Tony Duffin (Ana Liffey Drug Project)
    Panel Members: Ákos Topolánszky (European Social and Economic Committee / Hungarian Federation of the Drug Therapy Institutions), Róbert Csák (Hungarian Association on Addiction), Anna Tarján, Péter Sárosi (Rights Reporter Foundation)
    According to its last national drug strategy, Hungary was supposed to become “drug-free” by 2020. Despite this ambitious goal, the government failed to eliminate drug use – it only succeeded in nearly eliminating funding for treatment and harm reduction programs. Several key programs had to close down and the philosophy and practice of harm reduction became a taboo. Panellists in the policy dialogue will outline the current drug policy situation in Hungary, address the ethical dilemmas of civil society in a hostile political climate and present some survival strategies.
  • 11.00-11.30 Break
  • 11.30-12.20 Civil Society Monitoring & Data Collection
    Moderator: Rafaela Rigoni (C-EHRN)
    Speakers: Iga Jeziorska (C-EHRN) – Harm Reduction Essential Services, Tuukka Tammi (THL) – Hepatitis C, Daan van der Gouwe (Trimbos)- New Drug Trends, Guy Jones (TEDI) – New Drug Trends via TEDI, Laoise Darragh (C-EHRN) – Mental Health, Rafaela Rigoni (C-EHRN) – City Reports
    The session will briefly present the different publications for the C-EHRN Civil Society-led Monitoring in Europe 2023. These focus on 1) The state of implementation of harm reduction essential services in the cities covered by C-EHRN Focal Points, 2) The state of implementation of the continuum of care for Hepatitis C for people who use drugs in the same cities, 3) New Drug Trends captured by harm reduction providers and trends captured by drug checking services members of the TEDI network, 4) Mental Health of harm reduction staff, and 5) Emergent issues and harm reduction innovations in five European cities. Short presentations focusing on key messages will be provided by the authors, followed by a Q&A session.
  • 12.20-13.10 C-EHRN activities: Civil Society Involvement Case Studies, Harm Reduction in Prison, Advocacy, Drug Consumption Rooms, Harm Reduction and Gender
    Moderator: Tony Duffin (Ana Liffey Drug Project)
    Speakers: Péter Sárosi (Rights Reporter Foundation), Graham Shaw (Consultant), Beatrix Vas (UNITE), Roberto Perez Gayo (C-EHRN)
    This session will highlight different C-EHRN activities, which were carried out in 2023. Short presentations will be provided by C-EHRN experts, followed by a Q&A session.

You can also follow one of the parallel sessions on Tuesday via this link:

  • 16.00-17.30 Civil Society Involvement & Advocacy workshop
    Moderator: Péter Sárosi (Rights Reporter Foundation)
    This session will focus on the meaningful involvement of civil society in the field of drug policy. We will present the findings of a qualitative research, carried out by C-EHRN in 2023. The study consisted of focus group discussions, both with decision-makers and civil society representatives in four countries, including Finland, Ireland, Hungary and Greece. After the presentation of the findings, we will discuss the potential impact and follow-up activities.

The plenary sessions on Wednesday the 6th of December can be followed via this link. The streamed plenary sessions are the following:

  • 11.30-12.30 Migration and Drug Use SEMID- EU
    Moderator: 
    Machteld Busz (Mainline)
    The SEMID-EU project focuses on marginalised migrants who use drugs in the EU. The aim of the project is to see into the needs and (harm reduction) service access of various groups with a migration background. During this plenary, we will present the results from a literature research and Delphi round, from a community-led participatory research (100 interviews + focus groups across the cities of Amsterdam, Athens, Berlin and Paris) and a series of policy documents and fact sheets. A panel will discuss the implications of the project and will look for opportunities to improve the health and rights of migrants who use drugs in the EU.
  •  12.30-13.00 Plenary Session Closing
    Moderators: Tony Duffin (Ana Liffey Drug Project)
    Speakers: Katrin Schiffer (C-EHRN), Péter Sárosi (Rights Reporter Foundation) & Marta Pinto (University of Porto)
    This session will summarise and wrap up the outcomes of the Member and Expert Meeting 2023.

European Testing Week 2023 Autumn

The Autumn European Testing Week takes place on 20-27 November 2023.

Join the partner organisations – community, healthcare and policy institutions – in increasing access to testing and promoting awareness on the benefits of earlier hepatitis and HIV testing!

FP Meeting / C-EHRN Monitoring 2023, Lisbon

C-EHRN hosted this year’s FP Meeting in Lisbon on 30 – 31 March and launched the Civil Society led Monitoring of Harm Reduction 2023 work plan with new opportunities for exchange, consultation and synergy to continue our shared goals of Networking, Monitoring, Capacity Building and Advocacy.

Notable updates include:

  • HR in Prison practical toolbox building on previous years’ activities and existing guidelines and good practices
  • Civil Society Involvement (CSI) Case Studies building on a tool developed as part of the CSFD Project, including quality standards and principles for meaningful CSI. Focus groups and interviews in four different countries/cities to assess the level and quality of CSI will be arranged.
  • Establish an advocacy network of HR allies (mayors, MEPs, national MPs, national drug coordinators and journalists) to support our advocacy activities, with the support of the UNITE Network of MPs.

The meeting was grouped by sessions:

  • ‘Monitoring 2023’ session covered the framework for the C-EHRN Monitoring 2023 as well as monitoring developments and modifications. This includes the addition of new FPs, bringing the number to 43. Modifications include for HR Essentials and Hepatitis C, which will remain collected via a survey; for the data collection of New Drug Trends; and the new addition of city reports; as well as the framework for the report on the mental health of harm reduction staff (FPs have been contacted for interviews).
  • ‘City Reports’ sessions presented the basic framework and content of the city reports and selection criteria for 5 pilot cities for 2023; as well as the aim of the reports: advocacy, data collection and capacity building. Volunteer cities include: Warsaw, Luxembourg, London, Cracow, Lille, Dublin, Amsterdam, Athens and Rome.
  • Monitoring and Advocacy sessions focused on the needs of FPs to support / improve advocacy and how C-EHRN has been using the Monitoring results for advocacy.
  • FGDs capacity building and New Drug Trends 2023 sessions introduced the ‘Monitoring New Drug Trends in 2023’ plan – a newly introduced section of the survey – as well as ran focus groups following the FP decision in Athens in 2022 to collect data on this topic via Focus Group Discussions (FGD) to ensure more quality and reliability of data. These sessions included  capacity building on how to run an FGD, which several FPs are currently organising.

The next Expert and Member Meeting takes place in Budapest on 4 – 5 December.

Online Webinars 2022

Correlation – European Harm Reduction Network is excited to invite you to the online webinar series of its Civil Society Monitoring of Harm Reduction in Europe in 2021. In the coming months, we would like to invite you to join us in discussing the main key findings of our Data Report 2021 in a series of dialogues with harm reduction professionals, policymakers, researchers and European agencies, among others:

Webinar 01 | Launch Monitoring Report 2021
11th of May 16:00h – 16:45h

Webinar 02 | Hepatitis C & Drug Use
15th of June 16:00h – 17:00h

Webinar 03 | State & Challenges of Overdose Prevention 
13th of July 16:00h – 17:00h

Webinar 04COVID-19 Impacts on Harm Reduction
14th of September 16:00h – 17:00h

Webinar 05 | Monitoring New Drugs Trends
12th of October 16:00h – 17:00h

Developing a new Strategy for 2021-2025

Correlation – European Harm Reduction Network is excited to invite you to join us in our upcoming Harm Reduction Labs. Currently, the Network is developing a new Strategy for 2021-2025 through a process that includes all stakeholders in the Harm Reduction movement.

Running alongside the preparations for the upcoming European Harm Reduction Conference 2021, the Harm Reduction Labs will offer the possibility of exploring collective solutions and imagining what harm reduction can be. In addition to analysing current themes and approaches within the harm reduction movement, each Lab will offer space to come together and identify common and urgent future questions that address broader topics of social justice, bodily autonomy, and care, among others.

Programme:
HR Lab #1
 | Sex Work, Migration and Homelessness [30 September, 15h – 16:30h]
HR Lab #2 | Gender Identities, Gender Expressions and Sex Characteristics [7 October, 15h – 16:30h]
HR Lab #3 | Funding & Sustainability [14 October, 15h – 16:30h]
HR Lab #4 | Digital Transformation & Online Spaces [21 October, 15h – 16:30h]
HR Lab #5 | Youth & Recreational Settings [28 October, 15h – 16:30h]
HR Lab #6 | Stimulants [4 November, 15h – 16:30h]
HR Lab #7 | Community-Led Research [2 December, 15h – 16:30h]
HR Lab #8 | Care & Pleasure [9 December, 15h – 16:30h]

From your point of view, what is urgent for the harm reduction movement to consider in the coming period?

Please, register now to any of the Labs to share your thoughts with us.
If you have any questions, you may also contact Roberto Perez Gayo at rpgayo@correlation-net.org

Conference – Civil Society Involvement in Drug Policy

The CSIDP Conference will bring civil society organisations, national and European policy makers, and other stakeholders to discuss the importance of civil society’s involvement in drug policy for the first time. The conference will present the level of participation in European Member States, provide models of good practice and critically discuss potential bottlenecks and shortcomings. The following questions will be addressed: Why is civil society involvement important? What has been achieved so far? How can civil society’s involvement be improved? What are the main principles for meaningful participation, and what is needed at the European, national, and local levels?

The two Civil Society Fora – the one on Drugs and the one on HIV, Hepatitis and Tuberculosis – will present their activities on European and international levels. Relevant stakeholders, including governmental officials and civil society representatives, will share different approaches and perspectives. Interactive sessions will enable the participants to discuss civil society’s role and limitations and inspire each other to improve cooperation and the dialogue between civil society and policymakers.

Presentations:
Civil Society Involvement at the UN Level. Does it work? – Jamie Bridge [IDPC]
Funding Gap in Romania – Alina Bocai [ARAS]
Promoting Democracy, Improving Government, Renewing Trust – Lucy McTernan [OGP]
Encouraging Examples in Drug Policy – Manuel Cardoso [SICAD]
Roadmap Presentation – Marcus Keane [ALDP]
Assessment Report – Harald Lahuse, Marcus Martnes ,Uwe Verthein [ZIS Hamburg]